Literature DB >> 35157268

Llama DNA Immunization and Isolation of Functional Single-Domain Antibody Binders.

Frédéric Trempe1, Martin A Rossotti1, Tahir Maqbool2, C Roger MacKenzie1, Mehdi Arbabi-Ghahroudi3,4,5.   

Abstract

Genetic immunization is a simple, cost-effective, and powerful tool for inducing innate and adaptive immune responses to combat infectious diseases and difficult-to-treat illnesses. DNA immunization is increasingly used in the generation of monoclonal antibodies against targets for which pure proteins are unavailable or are difficult to express and purify (e.g., ion channels and receptors, transmembrane proteins, and emerging infectious pathogens). Genetic immunization has been successfully utilized in small inbred laboratory animals (mostly rodents); however, low immunogenicity of DNA/RNA injected into large mammals, including humans, is still a major challenge. Here, we provide a method for the genetic immunization of llamas, using a combination of biolistic transfection with a gene gun and intradermal injection with a DERMOJET® device, to elicit heavy-chain IgG responses against epidermal growth factor receptor (EGFR). We show the technique can be used to generate single-domain antibodies (VHHs) with nanomolar affinities to EGFR. We provide methods for gene gun bullet preparation, llama immunization, serology, phage-display library construction and panning, and VHH characterization.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Camelid; DERMOJET®; DNA immunization; Gene gun; Phage-display; Single-domain antibody; VHH

Mesh:

Substances:

Year:  2022        PMID: 35157268     DOI: 10.1007/978-1-0716-2075-5_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Single domain camel antibodies: current status.

Authors:  S Muyldermans
Journal:  J Biotechnol       Date:  2001-06       Impact factor: 3.307

2.  Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies.

Authors:  Greg Hussack; Mehdi Arbabi-Ghahroudi; C Roger Mackenzie; Jamshid Tanha
Journal:  Methods Mol Biol       Date:  2012
  2 in total
  1 in total

Review 1.  Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.

Authors:  Mehdi Arbabi-Ghahroudi
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.